Endpoint reviews with an FDA component
- Diabetic foot ulcers
- Diabetic macular oedema
- Diarrhoea-predominant irritable bowel syndrome
- Dysmenorrhea
- Epilepsy
- Epoietin alfa in chronic kidney disease
- Functional digestive disorders (post-prandial distress syndrome)
- Hereditary angioedema
- Hypogonadism
- Major depressive disorder
- Pain
- Pulmonary arterial hypertension
- Retinal vein occlusion
- Rheumatoid arthritis